Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-26

Clinical Trial Update: Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis [Phase 4]

View source ↗

Summary

Phase 4 pilot study assessing safety and efficacy of AzaSite (azithromycin) for blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 4 | Status: COMPLETED